205 related articles for article (PubMed ID: 19575453)
1. Aggravation by prostaglandin E2 of interleukin-6-dependent insulin resistance in hepatocytes.
Henkel J; Neuschäfer-Rube F; Pathe-Neuschäfer-Rube A; Püschel GP
Hepatology; 2009 Sep; 50(3):781-90. PubMed ID: 19575453
[TBL] [Abstract][Full Text] [Related]
2. Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.
Senn JJ; Klover PJ; Nowak IA; Zimmers TA; Koniaris LG; Furlanetto RW; Mooney RA
J Biol Chem; 2003 Apr; 278(16):13740-6. PubMed ID: 12560330
[TBL] [Abstract][Full Text] [Related]
3. Resistin disrupts glycogen synthesis under high insulin and high glucose levels by down-regulating the hepatic levels of GSK3β.
Song R; Wang X; Mao Y; Li H; Li Z; Xu W; Wang R; Guo T; Jin L; Zhang X; Zhang Y; Zhou N; Hu R; Jia J; Lei Z; Irwin DM; Niu G; Tan H
Gene; 2013 Oct; 529(1):50-6. PubMed ID: 23860320
[TBL] [Abstract][Full Text] [Related]
4. The peroxisome proliferator-activated receptor (PPAR) β/δ agonist GW501516 inhibits IL-6-induced signal transducer and activator of transcription 3 (STAT3) activation and insulin resistance in human liver cells.
Serrano-Marco L; Barroso E; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetologia; 2012 Mar; 55(3):743-51. PubMed ID: 22179221
[TBL] [Abstract][Full Text] [Related]
5. Modified Si-Miao-San extract inhibits inflammatory response and modulates insulin sensitivity in hepatocytes through an IKKβ/IRS-1/Akt-dependent pathway.
Liu K; Luo T; Zhang Z; Wang T; Kou J; Liu B; Huang F
J Ethnopharmacol; 2011 Jul; 136(3):473-9. PubMed ID: 21296137
[TBL] [Abstract][Full Text] [Related]
6. Activation of peroxisome proliferator-activated receptor-β/-δ (PPAR-β/-δ) ameliorates insulin signaling and reduces SOCS3 levels by inhibiting STAT3 in interleukin-6-stimulated adipocytes.
Serrano-Marco L; Rodríguez-Calvo R; El Kochairi I; Palomer X; Michalik L; Wahli W; Vázquez-Carrera M
Diabetes; 2011 Jul; 60(7):1990-9. PubMed ID: 21617181
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 induces cellular insulin resistance in hepatocytes.
Senn JJ; Klover PJ; Nowak IA; Mooney RA
Diabetes; 2002 Dec; 51(12):3391-9. PubMed ID: 12453891
[TBL] [Abstract][Full Text] [Related]
8. Resistin induces insulin resistance, but does not affect glucose output in rat-derived hepatocytes.
Liu F; Yang T; Wang B; Zhang M; Gu N; Qiu J; Fan HQ; Zhang CM; Fei L; Pan XQ; Guo M; Chen RH; Guo XR
Acta Pharmacol Sin; 2008 Jan; 29(1):98-104. PubMed ID: 18158871
[TBL] [Abstract][Full Text] [Related]
9. Irbesartan restores the in-vivo insulin signaling pathway leading to Akt activation in obese Zucker rats.
Muñoz MC; Argentino DP; Dominici FP; Turyn D; Toblli JE
J Hypertens; 2006 Aug; 24(8):1607-17. PubMed ID: 16877964
[TBL] [Abstract][Full Text] [Related]
10. High glucose induces suppression of insulin signalling and apoptosis via upregulation of endogenous IL-1beta and suppressor of cytokine signalling-1 in mouse pancreatic beta cells.
Venieratos PD; Drossopoulou GI; Kapodistria KD; Tsilibary EC; Kitsiou PV
Cell Signal; 2010 May; 22(5):791-800. PubMed ID: 20067833
[TBL] [Abstract][Full Text] [Related]
11. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
12. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes.
Wada T; Hoshino M; Kimura Y; Ojima M; Nakano T; Koya D; Tsuneki H; Sasaoka T
Am J Physiol Endocrinol Metab; 2011 Jun; 300(6):E1112-23. PubMed ID: 21386060
[TBL] [Abstract][Full Text] [Related]
13. 3-OH flavone inhibition of epidermal growth factor-induced proliferaton through blocking prostaglandin E2 production.
Shen SC; Ko CH; Hsu KC; Chen YC
Int J Cancer; 2004 Feb; 108(4):502-10. PubMed ID: 14696113
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-6 impairs the insulin signaling pathway, promoting production of nitric oxide in human umbilical vein endothelial cells.
Andreozzi F; Laratta E; Procopio C; Hribal ML; Sciacqua A; Perticone M; Miele C; Perticone F; Sesti G
Mol Cell Biol; 2007 Mar; 27(6):2372-83. PubMed ID: 17242212
[TBL] [Abstract][Full Text] [Related]
15. Epigallocatechin-3-gallate ameliorates insulin resistance in hepatocytes.
Ma SB; Zhang R; Miao S; Gao B; Lu Y; Hui S; Li L; Shi XP; Wen AD
Mol Med Rep; 2017 Jun; 15(6):3803-3809. PubMed ID: 28393248
[TBL] [Abstract][Full Text] [Related]
16. IL-22-mediated liver cell regeneration is abrogated by SOCS-1/3 overexpression in vitro.
Brand S; Dambacher J; Beigel F; Zitzmann K; Heeg MH; Weiss TS; Prüfer T; Olszak T; Steib CJ; Storr M; Göke B; Diepolder H; Bilzer M; Thasler WE; Auernhammer CJ
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1019-28. PubMed ID: 17204547
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide impairs insulin sensitivity via activation of phosphoinositide 3-kinase in adipocytes.
Wakayama S; Haque A; Koide N; Kato Y; Odkhuu E; Bilegtsaikhan T; Naiki Y; Komatsu T; Yoshida T; Yokochi T
Immunopharmacol Immunotoxicol; 2014 Apr; 36(2):145-9. PubMed ID: 24506665
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes.
Dajani OF; Meisdalen K; Guren TK; Aasrum M; Tveteraas IH; Lilleby P; Thoresen GH; Sandnes D; Christoffersen T
J Cell Physiol; 2008 Feb; 214(2):371-80. PubMed ID: 17654493
[TBL] [Abstract][Full Text] [Related]
19. Prostaglandin E2 regulates angiogenesis via activation of fibroblast growth factor receptor-1.
Finetti F; Solito R; Morbidelli L; Giachetti A; Ziche M; Donnini S
J Biol Chem; 2008 Jan; 283(4):2139-46. PubMed ID: 18042549
[TBL] [Abstract][Full Text] [Related]
20. ERK1/2 activation by angiotensin II inhibits insulin-induced glucose uptake in vascular smooth muscle cells.
Izawa Y; Yoshizumi M; Fujita Y; Ali N; Kanematsu Y; Ishizawa K; Tsuchiya K; Obata T; Ebina Y; Tomita S; Tamaki T
Exp Cell Res; 2005 Aug; 308(2):291-9. PubMed ID: 15921682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]